ロード中...
Inhibiting Arginine Methylation as a Tool to Investigate Cross-Talk with Methylation and Acetylation Post-Translational Modifications in a Glioblastoma Cell Line
Glioblastomas (GBM) are the most common grade 4 brain tumours; patients have very poor prognosis with an average survival of 15 months after diagnosis. Novel research lines have begun to explore aberrant protein arginine methylation (ArgMe) as a possible therapeutic target in GBM and ArgMe inhibitor...
保存先:
| 出版年: | Proteomes |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313862/ https://ncbi.nlm.nih.gov/pubmed/30347783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/proteomes6040044 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|